Company / Current Assets per Share
X4 Pharmaceuticals, Inc Current Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$45.90
FY2025
5-year range
$0.67 / $45.90
FY2021-FY2025
Trend
+6751.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share changed +6752% YoY in FY2025, a notable deviation from the 5-year average annual change of +1353%.
Based on SEC 10-K filings.
45.90 in FY2025 with a 5-year CAGR of +54.8%.
Improved from $4.57 to $45.90 over the past 3 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +115.7%
- 5-Year CAGR
- +54.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current assets per share increased 6751.9% year-over-year.
- Lowest current assets per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.53 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $45.90 | +6751.9% |
| FY2024 | $0.67 | -85.4% |
| FY2022 | $4.57 | -15.1% |
| FY2021 | $5.39 | +4.3% |
| FY2020 | $5.17 | +110.5% |
| FY2018 | $2.45 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026